These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29672347)
1. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method. Young SM; Kim YD; Lang SS; Woo KI Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347 [TBL] [Abstract][Full Text] [Related]
2. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Xu D; Liu Y; Xu H; Li H Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849 [TBL] [Abstract][Full Text] [Related]
3. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823 [TBL] [Abstract][Full Text] [Related]
4. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Chee E; Chee SP Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686 [TBL] [Abstract][Full Text] [Related]
5. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. Lee JM; Lee H; Park M; Baek S J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303 [TBL] [Abstract][Full Text] [Related]
6. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy]. Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335 [No Abstract] [Full Text] [Related]
7. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A]. Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients. Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation. Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450 [TBL] [Abstract][Full Text] [Related]
11. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Li D; Sun F Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385 [TBL] [Abstract][Full Text] [Related]
12. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results. Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous ipsilateral transconjunctival repair of upper and lower eyelid retraction in thyroid-associated ophthalmopathy. Lee NG; Habib L; Hall J; Freitag SK Orbit; 2019 Apr; 38(2):124-129. PubMed ID: 29742012 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease. Parsons SR; Wilson-Pogmore A; Sullivan TJ Front Ophthalmol (Lausanne); 2024; 4():1388197. PubMed ID: 38984143 [TBL] [Abstract][Full Text] [Related]
15. Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: a retrospective case series. Barlatay JMG; Boza CP; Basso TO; Benavente M; Hernández-Gauna GV; Premoli EJ Arq Bras Oftalmol; 2023; 86(5):e20230063. PubMed ID: 35544933 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease. Kozaki A; Nakamura H; Inoue T Int Med Case Rep J; 2018; 11():325-331. PubMed ID: 30519121 [TBL] [Abstract][Full Text] [Related]
18. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease. Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206 [TBL] [Abstract][Full Text] [Related]
19. Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Alkawas AA; Hussein AM; Shahien EA Clin Exp Ophthalmol; 2010 Oct; 38(7):692-7. PubMed ID: 20497432 [TBL] [Abstract][Full Text] [Related]
20. Stability of eyelid height after graded anterior-approach lid lowering for dysthyroid upper lid retraction. Shortt AJ; Bhogal M; Rose GE; Shah-Desai S Orbit; 2011 Dec; 30(6):280-8. PubMed ID: 22132845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]